ATXI
Closed
Avenue Therapeutics Inc
0.35
+0.15 (+74.74%)
Last Update: 01 Jul 2025 21:12:00
Yesterday: 0.2007
Day's Range: 0.3277 - 0.36
Send
sign up or login to leave a comment!
When Written:
1.165
Avenue Therapeutics Inc. is a pharmaceutical company that focuses on developing and commercializing intravenous (IV) tramadol, a synthetic opioid analgesic, for the management of moderate to moderately severe pain in acute care settings. The company was founded in 2015 and is headquartered in New York City. Avenue Therapeutics is a subsidiary of InvaGen Pharmaceuticals, a global pharmaceutical company that specializes in the development, manufacturing, and marketing of generic and specialty pharmaceuticals. The company's lead product candidate, IV tramadol, is currently in Phase III clinical trials and has the potential to become an alternative to traditional opioid painkillers, which carry a high risk of addiction and abuse. Avenue Therapeutics aims to provide a safer and more effective pain management option for patients in acute care settings.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








